Gas chromatography-mass spectrometric assay for propofol in cerebrospinal fluid of traumatic brain patients

  • Mariska Y. M. Peeters*
  • , Hiltjo Kuiper
  • , Ben Greijdanus
  • , Joukje van der Naalt
  • , Catherijne A. J. Knibbe
  • , Donald R. A. Uges
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

A sensitive gas chromatography-mass spectrometry method for measuring propofol in cerebrospinal fluid is described, validated and applied to four patients after traumatic brain injury. The limit of quantitation was 2 mu g/L using a volume of 0.5 mL. The inter- and intra-assay coefficients of variation were 5.9 and 5.1%, respectively. The assay covers the linear concentration range of 2-50 mu g/L, which is relevant in clinical pharmacokinetic studies when propofol is used in the Intensive Care Unit as a sedative agent or to lower the intracranial pressure. (c) 2007 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)635-639
Number of pages5
JournalJournal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
Volume852
Issue number1-2
DOIs
Publication statusPublished - 1-Jun-2007

Keywords

  • propofol
  • CSF
  • GC-MS
  • HUMAN PLASMA
  • BLOOD
  • QUANTITATION
  • EXTRACTION
  • ANESTHESIA
  • INFUSION
  • SAMPLES
  • HPLC

Fingerprint

Dive into the research topics of 'Gas chromatography-mass spectrometric assay for propofol in cerebrospinal fluid of traumatic brain patients'. Together they form a unique fingerprint.

Cite this